Saturday, April 20, 2024

Addressing the Opioid Crisis: How the Support Act Aims to Restore Hope and Healing

Similar articles

Despite the likelihood of major healthcare legislation being low due to an evenly divided Congress with upcoming elections, the opioid crisis is being addressed through the SUPPORT Act in the US. This act, which passed the House with bipartisan support, is primarily focused on reducing the impact of fentanyl in rural areas. The Act aims to achieve this through training and education initiatives.

The SUPPORT Act also reauthorizes support for substance use disorder treatment. This move is particularly significant in the context of the opioid epidemic, which has been intensified by fentanyl and synthetic opioids. The Act’s reauthorization of support for substance use disorder treatment is a key response to this evolving crisis.

Another significant element of the SUPPORT Act is its placement of the animal tranquilizer xylazine, also known as tranq, under Schedule 3 of the Controlled Substances Act. Xylazine, when mixed with heroin and fentanyl, has been linked to increased risks of overdose. By placing xylazine under Schedule 3 of the Controlled Substances Act, the SUPPORT Act aims to reduce these risks.

Comprehensive Measures in the SUPPORT Act: Addressing Opioid Risks and Maternal Care

The SUPPORT Act also continues funding for substance use disorder treatment for pregnant and postpartum women. This provision ensures that these women have access to the necessary support and treatment they need. In addition, the Act ensures Medicaid access to medication-assisted treatment (MAT), including treatments involving buprenorphine, methadone, and naltrexone.

Moreover, the SUPPORT Act aims to restore hope and healing to those affected by the opioid crisis. It does so with support from healthcare workers and law enforcement agencies. The Act builds upon the 2018 SUPPORT Act and has been backed by the American Hospital Association for extending Medicaid coverage for MAT.

Opioid Crisis

A Holistic Approach to Tackling the Opioid Crisis

The SUPPORT Act is a significant step in addressing the opioid crisis. With its focus on training and education, reauthorization of support for substance use disorder treatment, regulation of xylazine, and extension of Medicaid coverage for MAT, the Act represents a comprehensive response to the opioid epidemic.

The SUPPORT Act, focuses on reducing the impact of fentanyl in rural areas, reauthorizing support for substance use disorder treatment, placing xylazine under Schedule 3 of the Controlled Substances Act, continuing funding for pregnant and postpartum women’s substance use disorder treatment, and ensuring Medicaid access to MAT, shows a comprehensive response to the opioid crisis. The Act’s focus on restoring hope and healing with support from healthcare workers and law enforcement, building upon the 2018 SUPPORT Act, and being backed by the American Hospital Association for extending Medicaid coverage for MAT, demonstrates a significant step in addressing the opioid crisis.

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Latest article